Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease
- 30 November 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (5) , 689-699
- https://doi.org/10.1016/s0168-8278(96)80240-6
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The acid-labile subunit (ALS) in acute and chronic liver disease (CLD)Hepatology, 1995
- Short-term effect of recombinant human growth hormone in patients with alcoholic cirrhosisJournal of Hepatology, 1994
- Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serumFEBS Letters, 1994
- Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosisJournal of Hepatology, 1993
- Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humansJournal of Clinical Endocrinology & Metabolism, 1992
- Insulin‐like growth factors I and IIEuropean Journal of Biochemistry, 1990
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- Growth Hormone and Carbohydrate Intolerance in CirrhosisHormone and Metabolic Research, 1988
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Impaired glucose tolerance and growth hormone in chronic liver disease.Gut, 1981